Adial Pharmaceuticals (ADIL) Assets Average (2022 - 2024)
Adial Pharmaceuticals' Assets Average history spans 3 years, with the latest figure at $5.8 million for Q3 2024.
- For Q3 2024, Assets Average rose 75.46% year-over-year to $5.8 million; the TTM value through Sep 2024 reached $5.8 million, up 75.46%, while the annual FY2023 figure was $5.2 million, N/A changed from the prior year.
- Assets Average for Q3 2024 was $5.8 million at Adial Pharmaceuticals, roughly flat from $5.8 million in the prior quarter.
- Across five years, Assets Average topped out at $12.4 million in Q2 2022 and bottomed at $3.3 million in Q3 2023.
- The 3-year median for Assets Average is $5.8 million (2024), against an average of $6.2 million.
- The largest annual shift saw Assets Average crashed 69.14% in 2023 before it surged 75.46% in 2024.
- A 3-year view of Assets Average shows it stood at $6.7 million in 2022, then plummeted by 43.57% to $3.8 million in 2023, then surged by 53.36% to $5.8 million in 2024.
- Per Business Quant, the three most recent readings for ADIL's Assets Average are $5.8 million (Q3 2024), $5.8 million (Q2 2024), and $5.7 million (Q1 2024).